Skip to main content

Table 4 Use of selected non-pain-related medications among study subjects*

From: Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study

  Patients with painful neuropathies (N = 31,688) Comparison group (N = 31,688) P-Value
Number receiving    
   General anti-infectives systemic 14,451 (45.6) 10,953 (34.6) <0.01
   Cough and cold preparations 6,682 (21.1) 5,188 (16.4) <0.01
   Dermatologicals 7,464 (23.6) 5,415 (17.1) <0.01
   ACE inhibitors 8,421 (26.6) 5,327 (16.8) <0.01
   Antiulcerants 7,525 (23.7) 3,819 (12.1) <0.01
   Beta-blocking agents 6,148 (19.4) 4,446 (14.0) <0.01
   Anti-asthma and COPD products 5,534 (17.5) 3,450 (10.9) <0.01
   Drugs used in diabetes 4,553 (14.4) 3,996 (12.6) <0.01
   Diuretics 5,081 (16.0) 4,224 (13.3) <0.01
   Plain antispasmodics and anticholinergics 6,267 (19.8) 4,133 (13.0) <0.01
   Thyroid therapy 3,909 (12.3) 3,494 (11.0) <0.01
   Calcium antagonists 4,340 (13.7) 3,565 (11.3) <0.01
   Statins 4,377 (13.8) 1,900 (6.0) <0.01
   Antidiarrhoeals, oral electrolyte replacers and intestinal anti-inflammatories 3,336 (10.5) 2,116 (6.7) <0.01
   Non-narcotics and anti-pyretics 2,711 (8.6) 1,802 (5.7) <0.01
   Respiratory system and nasal preparations 2,558 (8.1) 1,722 (5.4) <0.01
   Angiotensin-II antagonists 2,532 (8.0) 1,764 (5.6) <0.01
   Heparins 2,412 (7.6) 1,573 (5.0) <0.01
   Ophthalmologicals 2,158 (6.8) 1,581 (5.0) <0.01
   Urologicals 2,614 (8.2) 1,406 (4.4) <0.01
   Systemic antihistamines 2,313 (7.3) 1,797 (5.7) <0.01
   Anti-gout preparations 2,305 (7.3) 1,531 (4.8) <0.01
   Nitrites and nitrates 2,016 (6.4) 991 (3.1) <0.01
   Mineral supplements 2,173 (6.9) 1,393 (4.4) <0.01
   Diagnostic agents 2,201 (6.9) 1,090 (3.4) <0.01
Number receiving    <0.01
   None of the above 5,114 (16.1) 8,329 (26.3)  
   1 of the above 5,020 (15.8) 6,513 (20.6)  
   2 of the above 4,329 (13.7) 4,460 (14.1)  
   3 of the above 3,612 (11.4) 3,415 (10.8)  
   ≥ 4 of above 13,613 (43.0) 8,971 (28.3)  
   Any of above 26,574 (83.9) 23,359 (73.7) <0.01
  1. *Unless otherwise indicated, all values are number (%)
  2. ACE: Angiotensin-converting enzyme; COPD: Chronic obstructive pulmonary disease